THE IMPROVEMENT OF BETULIN-3, 28-DIPHOSPHATE WATER-SOLUBILITY BY COMPLEXATION WITH AMINES–MEGLUMINE AND XYMEDON
Objective: To study betulin-3,28-diphosphate (BDP) water solubility improved by forming salt complexes with hydrophilic amino alcohols: meglumine as acidosis corrector and xymedon as the water-soluble antioxidant.
Methods: We used 13C-, 31P-NMR, UV-spectroscopy and potentiometric titration to study the BDP-amine salt complexes formation and their solubility using HPLC-analysis.
Results: The participation of xymedon in the proton transfer reaction with BDP in aqueous solutions was confirmed by the bathochromic shift of the carbonyl band from 299.1 nm to 304.2 nm, and by a hyperchromic effect (molar extinction ε from 8508 to 10 441 l·mol-1·cm-1) in UV-spectra. BDP complexation with meglumine was estimated by UV-spectral molar ratio method at 256 nm. Molar ratio of BDP-amine complexes (1:4) was proved by 31P-NMR. The chemical shift of phosphorus at C-3 atom of BDP (δ =-0.58 ppm) changed to+3.39 ppm, and at C-28 atom (δ =+0.28 ppm)–to+4.60 ppm. BDP solubility increased 100-600 fold according to HPLC-analysis.
Conclusion: BDP interaction with amine in an aqueous solution was shown to proceed via a proton transfer due to relatively weak forces such as London forces, hydrogen bonding, electrostatic and hydrophobic interactions. In general, the formation of BDP salt complexes with amines in solution determines BDP water solubility. Water-soluble BDP enables to develop hydrophilic dosage forms.
2. Perez J, Shen C-chang, Ragasa CY. Triterpenes from ceriops decandra (Griff.) W. Theob. AJPCR 2017;10:244-6.
3. Evanjaline M, Vr M. Determination of bioactive components of caralluma umbellata haw. (Apocynaceae) by gas chromatography and mass spectroscopy analysis. AJPCR 2018;11:194-9.
4. Meng Q, Zhou X, Liu L, Fu S. Research progress in the promissing natural product-betulin. Biomed J Sci Tech Res 2018;8:1-6.
5. Furtado NAJC, Pirson L, Edelberg H, Miranda LM, Loira-Pastoriza C, Preat V, et al. Pentacyclic triterpene bioavailability: an overview of in vitro and in vivo studies. Molecules 2017;22:1-24.
6. Yogeeswari P, Sriram D. Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 2005;12:657–66.
7. So HM, Eom HJ, Lee D, Kim S, Kang KS, Lee IK, et al. Bioactivity evaluations of betulin identified from the bark of Betula platyphylla var. japonica for cancer therapy. Arch Pharm Res 2018;41:815-22.
8. Kim KJ, Lee Y, Hwang HG, Sung SH, Lee M, Son Y. Betulin suppresses osteoclast formation via down-regulating NFATc1. J Clin Med 2018;7:1-11.
9. Abyshev AZ, Abyshev RA, Nguyen VH, Morozova VA. Betulenol derivatives as potential anti-HIV agents. Med Academic J 2013;13:15-32.
10. ?ao D, Zhao G, Yan W. Solubilities of betulin in fourteen organic solvents at different temperatures. J Chem Eng Data 2007;52:1366-8.
11. Dai L, Li D, Cheng J, Liu J, Deng LH, Wang LY. Water soluble multiarm-polyethylene glycol-betulinic acid prodrugs: design, synthesis, and in vivo effectiveness. Polym Chem 2014;5:5775-83.
12. Mikhailenko MA, Shakhtshneider TP, Eltsov IV, Kozlov AS, Kuznetsova SA, Karacharov ??, et al. Supramolecular architecture of betulin diacetate complexes with arabinogalactan from Larix sibirica. Carbohydr Polym 2016;138:1-7.
13. Drag Zalesinska M, Kulbacka J, Saczko J, Wysocka T, Zabel M, Surowiak P, et al. Esters of betulin and betulinic acid with amino acids have improved water solubility and are selectively cytotoxic toward cancer cells. Bioorg Med Chem Lett 2009;19:4814-7.
14. Zhao H, Holmes SS, Baker GA, Challa S, Bose HS, Song Z. Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors. J Enzyme Inhibition Med Chem 2012;27:715-21.
15. Martin DE, Power MD. Pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid. Patent WO/2005/090380; 2005.
16. Bureeva S, Andia Pravdivy J, Symon A, Bichucher A, Moskaleva V, Popenko V, et al. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates. Bioorg Med Chem 2007;15:3489–98.
17. Tubek B, Smuga D, Smuga M, Wawrze?czyk C. Synthesis of 28-O-(1,2-Diacyl-SN-glycero-3-phospho)-betulin. Synthetic Communications 2012;42:3648–54.
18. Melnikova NB, Malygina DS, Klabukova IN, Belov DV, Vasin VA, Petrov PS, et al. Physico-chemical properties and in vitro biological activity experiments. Molecules 2018;23:E1175.
19. Krasutsky PA, Carlson RM, Karim MR. Triterpenes having antibacterial activity. U. S. Patent US 6,689,767 B2; 2004.
20. Krasutsky PA, Carlson RM, Karim MR. Triterpenes having human antifungal and antiyeast activity. U. S. Patent US 6,642,217 B2; 2003.
21. Amjad M, Carlson RM, Karim MR, Krasutsky PA. Inhibition of epstein-barr virus by the triterpenoid betulin diphosphate and uvaol. J Microbiol Biotechnol 2004;14:1086–8.
22. Chrobak E, Bebenek E, Kadela Tomanek M, Latocha M, Jelsch Ch, Wenger E, et al. Betulin phosphonates; synthesis, structure, and cytotoxic activity. Molecules 2016;21:1123.
23. Vorobyova O, Deryabina O, Malygina D, Plotnikova N, Solovyeva A, Belyaeva K, et al. Betulin-3,28-diphosphate as a component of combination cytostatic drugs for the treatment of ehrlich ascites carcinoma in vitro and in vivo experiments. Sci Pharm 2018;86:17.
24. Basavaraj S, Sihorkar V, Shantha Kumar TR, Sundaramurthi P, Srinivas NR, Venkatesh P, et al. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-b-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component. Pharm Dev Technol 2006;11:443–51.
25. Mehramizi A, Alijani B, Pourfarzib M, Dorkoosh FA, Rafiee Tehrani M. Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system. Drug Dev Ind Pharm 2007;33:812–23.
26. Izmaylov SG, Parshikov VV. Ksimedon: nastoyashchee i budushchee. Nizhny Novgorod Med J 2002;3:81–7.
27. Kuznetsova SA, Skvortsova GP, Maliar IN, Skurydina ES, Veselova OF. Extraction of betulin from birch bark and study of its physico-chemical and pharmacological properties. Russ J Bioorganic Chem 2014;40:742–7.
28. Jouyban A. Handbook of solubility data for pharmaceuticals. 1st ed. New York: Taylor and Francis Group; 2010.
29. Packer L. Catalase in vitro. In: Methods in enzymology. Vol. CV. Cambridge: Academic Press: 1984.
30. Sibgatullina GV, Khartendinova LR, Gumerova EA, Akulov AN, Kostyukova YuA, Nikonorova NA, et al. Methods for determining the redox status of cultured plant cells. Kazan (Russia): Kazan (Privolzhsky) Federal University: 2011.
31. Kochetov GA. Practical guide to enzymology. 2nd ed. Severin SE. editor. Moscow: High School: 1980.
32. Ryzhova ES, Panteleev DA, Chudetskaya YV, Volkov AA, Melnikova NB, Gulenova MV, et al. Chemical properties and immunotropic activity of the products from reaction of N-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrimidinesulfone)-N?-isonicotinoylhydrazide with acids and bases in aqueous media. Pharm Chem J 2010;44:205–12.
33. Williams VR, Williams HB. Basic physical chemistry for the life sciences. 2nd ed. San Francisco: W. H. Freeman and Co. Ltd.; 1973.
34. De Stefano C, Giuffre O, Milea D, Rigano C, Sammartano S. Speciation of phytate ion in aqueous solution. Non covalent interactions with biogenic polyamines. Chem Spec Bioavailab 2002;15:29–36.
35. Melnikova NB, Malygina DS, Solovyeva ON, Zhiltsova OE, Vasin VA, Petrov PS, et al. Betulin-3,28-diphosphate salt complexes with amines and their antioxidant activity. Int J Pharm Pharm Sci 2018;10:87–95.
This work is licensed under a Creative Commons Attribution 4.0 International License.